Thermo Fisher Scientific Financials

Thermo Fisher Scientific

TMO • NYSE •

Values in thousands	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Revenue	$10,345,000	$10,886,000	$10,574,000	$10,687,000
Gross Profit	4,217,000	4,496,000	4,429,000	4,364,000
EBITDA	2,556,000	1,854,000	3,061,000	2,794,000
EBIT	1,720,000	1,015,000	2,208,000	1,939,000
Net Income	1,328,000	1,630,000	1,715,000	1,361,000
Net Change In Cash	10,345,000	10,886,000	10,574,000	10,687,000
Cost of Revenue				-359,000
Free Cash Flow	904,000	3,318,000	2,082,000	1,256,000
Cash	5,506,000	8,077,000	6,151,000	3,133,000
Basic Shares	384,000	388,000	388,000	388,000

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$42,857,000	$44,915,000	$39,211,000	$32,218,000
Gross Profit	17,562,000	19,500,000	20,234,000	16,505,000
EBITDA	6,859,000	12,056,000	12,166,000	10,202,000
EBIT	6,859,000	8,393,000	10,028,000	7,794,000
Net Income	5,995,000	6,950,000	7,725,000	6,375,000
Net Change In Cash	42,857,000	44,915,000	39,211,000	32,218,000
Cost of Revenue		4,185,000	-6,039,000	7,738,000
Free Cash Flow	6,927,000	6,911,000	7,020,000	6,815,000
Cash	8,077,000	8,524,000	4,477,000	10,325,000
Basic Shares	388,000	394,000	397,000	399,000